sábado, 14 de noviembre de 2026
BuscarExplore
es.via.news
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 18, 2026

5 Financial Transaction Stocks to Watch Despite Elevated Expense Level

View original at finance.yahoo.com
5 Financial Transaction Stocks to Watch Despite Elevated Expense Level The Financial Transaction Services industry is likely to benefit from expanding global trade, rising international travel and growing demand for seamless cross-border payments and remittances…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The Financial Transaction Services industry is likely to benefit from expanding global trade, rising international travel and growing demand for seamless cross-border payments and remittances

    80% confidence

  • The top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one

    80% confidence

  • Visa carries a Zacks Rank #3 (Hold)

    80% confidence

  • In the past five years, the Financial Transaction Services industry traded as high as 36.92X, as low as 18.15X and at the median of 22.24X on a forward P/E basis

    80% confidence

  • Zacks Consensus Estimate for Visa's fiscal 2026 earnings is $12.84 per share, indicating an 11.9% rise from the year-ago figure

    80% confidence

  • The Zacks Financial Transaction Services industry currently carries a Zacks Industry Rank #135, placing it in the bottom 44% of 243 Zacks industries

    80% confidence

  • Fiserv's earnings beat estimates in three of the last four quarters and missed once

    80% confidence

  • Global Payments carries a Zacks Rank #2 (Buy)

    80% confidence

  • Fidelity National's earnings beat estimates in three of the last four quarters and matched once, with average surprise of 1.64%

    80% confidence

  • Mastercard's earnings beat estimates in each of the last four quarters, with an average surprise of 5.48%

    80% confidence

  • Visa's earnings beat estimates in each of the last four quarters, with an average surprise of 2.12%

    80% confidence

  • The Financial Transaction Services industry has declined 24.3% compared with the Business Services sector's decline of 24.4% over the past year

    80% confidence

  • The Financial Transaction Services industry is currently trading at a forward 12-month P/E of 18.15X, compared with the S&P 500's 22.51X and the sector's 18X

    80% confidence

  • Fidelity National carries a Zacks Rank #3 (Hold)

    80% confidence

  • With expectations for interest rate cuts in 2026, companies may increasingly use debt financing to fund acquisitions and accelerate growth

    80% confidence

  • Mastercard carries a Zacks Rank #3 (Hold)

    80% confidence

  • Zacks Consensus Estimate for Mastercard's 2026 earnings is $19.38 per share, indicating a 13.9% rise from the year-ago figure

    80% confidence

  • Zacks Consensus Estimate for Global Payments' 2026 earnings is $13.85 per share, indicating a 13.3% rise from the 2025 estimate

    80% confidence

  • Persistent inflation and tariff pressures may further strain consumer budgets in the financial transaction services space

    80% confidence

  • Zacks Consensus Estimate for Fiserv's 2026 earnings is $8.14 per share, with revenue consensus implying 3.4% improvement from year-ago

    80% confidence

  • Fiserv carries a Zacks Rank #3 (Hold)

    80% confidence

  • Zacks Consensus Estimate for Fidelity National's 2026 earnings is $6.27 per share, indicating an improvement of 8.7% from the 2025 estimate

    80% confidence

  • Global Payments' earnings beat estimates in three of the last four quarters and missed once, with an average surprise of 1.93%

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,580 documentos fuente archivados
Consulta estos datos → isubstrate.com
5 Financial Transaction Stocks to Watch Despite Elevated Expense Level — Source | Via News | es.via.news